Harmony Operating Cycle from 2010 to 2026

HRMY Stock  USD 38.55  0.68  1.80%   
Harmony Biosciences Operating Cycle yearly trend continues to be fairly stable with very little volatility. Operating Cycle will likely drop to 64.63 in 2026. During the period from 2010 to 2026, Harmony Biosciences Operating Cycle regression line of annual values had r-squared of  0.74 and arithmetic mean of  329.38. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
68.03
Current Value
64.63
Quarterly Volatility
223.78048826
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Harmony Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harmony Biosciences' main balance sheet or income statement drivers, such as Tax Provision of 55.9 M, Net Interest Income of 988.5 K or Depreciation And Amortization of 16.4 M, as well as many indicators such as Price To Sales Ratio of 2.99, Dividend Yield of 0.0 or PTB Ratio of 2.81. Harmony financial statements analysis is a perfect complement when working with Harmony Biosciences Valuation or Volatility modules.
  
Build AI portfolio with Harmony Stock
Check out the analysis of Harmony Biosciences Correlation against competitors.

Latest Harmony Biosciences' Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Harmony Biosciences Holdings over the last few years. It is Harmony Biosciences' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harmony Biosciences' overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Harmony Operating Cycle Regression Statistics

Arithmetic Mean329.38
Geometric Mean224.12
Coefficient Of Variation67.94
Mean Deviation213.53
Median510.88
Standard Deviation223.78
Sample Variance50,078
Range452
R-Value(0.86)
Mean Square Error13,919
R-Squared0.74
Slope(38.11)
Total Sum of Squares801,243

Harmony Operating Cycle History

2026 64.63
2025 68.03
2024 59.16
2023 62.64
2022 64.42
2021 70.78
2020 100.98

About Harmony Biosciences Financial Statements

Harmony Biosciences investors use historical fundamental indicators, such as Harmony Biosciences' Operating Cycle, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Harmony Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Cycle 68.03  64.63 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Harmony Stock Analysis

When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.